InnovAge Holding Corp. (INNV) - Stock Analysis

Last updated: Sep 19, 2026

Research Idea

Research content for general circulation. Not individualized advice. Methodology & Disclosures

InnovAge (INNV) demonstrates strong operational turnaround with positive adjusted EBITDA, expanding participant base, joint ventures for growth, and robust technical momentum with a 47% stock increase over a month. Its sustainable earnings and strategic partnerships support near-term appreciation potential in healthcare services.

Loading chart data...

Idea window: 2/5/2026 – 2/12/2026Sector: Healthcare

AI Analyst Overview

Last Price
$9.27
Market Cap
$1.26B
1D Return
-2.93%
YTD Return
+78.61%

Loading chart data...

Valuation Metrics

P/E
-447.8
P/B
5.3
P/S
1.3
EV/EBITDA
42.3
Div Yield
—

Fundamental Analysis

5.0

Key Financial Insights: • Strong Free Cash Flow • Thin Profit Margins • Tight Liquidity Position INNV generates solid free cash flow and is improving operationally, but thin profitability, tight liquidity, negative retained earnings, and a high EV/EBITDA multiple warrant caution.

CashFlow
ValuationRisk

Price Behavior

5.0

Key Price Behavior Insights: • Sideways trading • Resistance tests • Recent rebound Support Level: $10.70–$10.75 (stronger: $10.52–$10.60) Resistance Level: $11.03–$11.04 INNV is range-bound with neutral momentum; watch for a breakout above $11.03–$11.04 or support hold near $10.70–$10.75.

RangeBound
Watchlist

Sentiment & News

6.0

Key News Insights: • EBITDA expansion • Census growth • Earnings miss InnovAge's stronger revenue, census, EBITDA, and institutional buying signal improving fundamentals, though its earnings miss may temper near-term sentiment.

OperationalGrowth
EarningsMiss
AI

AI Summary

6.0
Neutral

INNV has evolved from a turnaround bet into an execution test: its strong census growth, 9.6% adjusted EBITDA margin, and free-cash-flow generation must translate into durable GAAP profitability despite slower reimbursement growth and loss-making Florida expansion; investors should demand fiscal-2027 margin resilience and EBITDA delivery near the $105–$115M guide before underwriting further upside at its premium valuation.

MarginExpansion
ReimbursementRisk
Execution
AI summary updated 36 days ago

Description

InnovAge Holding Corp. operates a Program of All-Inclusive Care for the Elderly (PACE) model, delivering both in-home and center-based medical and support services for seniors who require assistance to remain in their communities. The company serves about 6,850 participants through 18 centers across Colorado, California, New Mexico, Pennsylvania and Virginia, and offers care management, skilled and personal care, therapy, dental and mental health services, meals and transportation. Founded in 2007 and headquartered in Denver, it adopted the InnovAge name in January 2021.

Idea History

DateCloseTickerCompanySummaryStatusP/L
Feb 5Feb 12INNVInnovAge Holding Corp.
InnovAge (INNV) demonstrates strong operational turnaround with positive adjusted EBITDA, expanding participant base, joint ventures for growth, and robust technical momentum with a 47% stock increase over a month. Its sustainable earnings and strategic partnerships support near-term appreciation potential in healthcare services.
Closed+11.8%
Research content for educational purposes only. Not investment advice. All decisions are your responsibility.